Literature DB >> 23353796

Effective volume of ropivacaine 0.75% through a catheter required for interscalene brachial plexus blockade.

Catherine Vandepitte1, Philippe Gautier, Daquan Xu, Emine A Salviz, Admir Hadzic.   

Abstract

BACKGROUND: Ultrasound guidance during peripheral nerve blocks has allowed for reduction in dose and volume of local anesthetic required to accomplish successful blockade using multiple injections through a needle. The authors undertook this study to determine the minimal effective volume required to accomplish successful interscalene brachial plexus block (ISB) through the catheter.
METHODS: After obtaining institutional ethics committee approval and written informed consent, patients aged 18-75 yr and scheduled for arthroscopic shoulder surgery under ISB were enrolled. All patients using a step-up/step-down method and the starting dose of 15 ml of 0.75% ropivacaine received an ultrasound-guided ISB catheter. The injection volume was increased or decreased by 1 ml in case of block failure or block success, respectively.
RESULTS: The authors found that the proportion of patients with successful blockade increased sharply from approximately 57% at 6 ml to 100% by 7 ml, indicating that a small increase in volume of ropivacaine 0.75% markedly affects the success rate. A total of 12 ISB with injection volume less than 7 ml resulted in successful anesthesia within 30 min, yielding an ED95 of 7 ml (95% CI 6.8-7.2) ropivacaine 0.75%. For the group as a whole, the median (min-max) sensory block onset time was 5 (5-20) min, the median (min-max) motor blocks for the biceps and the deltoid muscles were 7.5 (5-15) min and 10 (5-15) min, respectively. The median (min-max) block duration was 8.9 (3-15) h.
CONCLUSIONS: An injection of a minimum of 7 ml of ropivacaine 0.75% through the catheter is required for success rate and timely onset of surgical anesthesia with ISB.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23353796     DOI: 10.1097/ALN.0b013e3182850dc7

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  6 in total

1.  Effects of Different 0.2% Ropivacaine Infusion Regimens for Continuous Interscalene Brachial Plexus Block on Postoperative Analgesia and Respiratory Function After Shoulder Arthroscopic Surgery: A Randomized Clinical Trial.

Authors:  Yan Meng; Sheng Wang; Wei Zhang; Chunlin Xie; Xiaoqing Chai; Shuhua Shu; Yu Zong
Journal:  J Pain Res       Date:  2022-05-12       Impact factor: 2.832

2.  The median effective analgesic concentration of ropivacaine in ultrasound-guided interscalene brachial plexus block after arthroscopic rotator cuff repair.

Authors:  Cheng Xu; Fei Gu; Yang Liu; Rui Chen; Chengyu Wang; Jie Lu
Journal:  Front Pharmacol       Date:  2022-08-17       Impact factor: 5.988

3.  Continuous incremental interscalene block for proximal humerus in patients with severe pulmonary injury.

Authors:  Sandeep Diwan; Abhijit Nair; Bharati Adhye; Parag Sancheti
Journal:  Indian J Anaesth       Date:  2022-06-21

4.  The estimation of minimum effective volume of 0.5% ropivacaine in ultrasound-guided interscalene brachial plexus nerve block: A clinical trial.

Authors:  Kailash Mittal; Sarita Janweja; Pushpender Sangwan; Deepa Agarwal; Himani Tak
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2019 Jan-Mar

5.  Local anesthetic volume in ultrasound-guided interscalene block and opioid consumption during shoulder arthroscopic surgery: A retrospective comparative study.

Authors:  Jung A Lim; Hyungseop Lim; Ji Hyeon Lee; Sang Gyu Kwak; Jong Hae Kim; Seok Young Song; Woon Seok Roh
Journal:  Medicine (Baltimore)       Date:  2021-07-09       Impact factor: 1.817

6.  Dose-response studies of Ropivacaine in blood flow of upper extremity after supraclavicular block: a double-blind randomized controlled study.

Authors:  Ting Li; Qiguang Ye; Daozhu Wu; Jun Li; Jingui Yu
Journal:  BMC Anesthesiol       Date:  2017-12-02       Impact factor: 2.217

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.